Fentanyl Overdose – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Fentanyl, a synthetic opioid, is employed in the management of intense pain. It possesses a potency 50 to 100 times greater than that of morphine. There are two categories of fentanyl: pharmaceutical and nonpharmaceutical. Medical professionals prescribe the former, and is available in various forms like pills, lozenges, nasal or sublingual sprays, skin patches, and injections. On the other hand, nonpharmaceutical fentanyl is produced illicitly and is often mixed as a powder or liquid with illegal substances such as cocaine, methamphetamine, and heroin or used in counterfeit prescription pills. Illicit drugs known as fentanyl analogues, including acetyl fentanyl, furanyl fentanyl, carfentanil, and U-47700, share chemical structures that resemble but are not identical to fentanyl. Identifying these analogues is challenging as they necessitate specialized toxicology tests for detection. While some fentanyl analogues are less potent than fentanyl, others are significantly stronger. Carfentanil, the most potent fentanyl analogue in the United States, is approximately 10,000 times more potent than morphine. Similar to other opioids, a fentanyl overdose can lead to symptoms like constricted "pinpoint" pupils, choking or gurgling sounds, cold and clammy skin, loss of consciousness, and slow, weak, or absent breathing. Naloxone is a medication that can swiftly reverse opioid effects and restore normal breathing within 2 to 3 minutes. Timely administration of naloxone can prevent fatalities resulting from fentanyl or any other opioid overdose.
Thelansis’s “Fentanyl Overdose Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Fentanyl Overdose treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights of Fentanyl Overdose across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Fentanyl Overdose Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
Comments
Post a Comment